[Evaluation of anticancerous and related drugs: European and American experiences and perspectives].
Soria
J C
JC
Centre des malades du sein et service d'oncologie médicale, hôpital Saint-Louis, Paris.
Marty
M
M
D016588:Anticarcinogenic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D018450:Disease Progression; D018572:Disease-Free Survival; D004341:Drug Evaluation; D005060:Europe; D005544:Forecasting; D006801:Humans; D015203:Reproducibility of Results; D018570:Risk Assessment; D015996:Survival Rate; D014481:United States; D014486:United States Food and Drug Administration
D016588:Anticarcinogenic Agents